Is the L-tryptophan metabolite quinolinic acid responsible for eosinophilic fasciitis?

Clinical and Experimental Medicine

Volumn 6, Issue 2, 2006, Pages 60-64

  Noakes, R ^a   Spelman, L ^b   Williamson, R ^c  

^a GREENSLOPES PRIVATE HOSPITAL   (Australia)

^b South East Dermatology ^*  (Australia)

^c SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

Author keywords

Eosinophilic fasciitis; Indoleamine 2,3 dioxygenase; Interferon gamma; Quinolinic acid; Transforming growth factor beta 1

Indexed keywords

GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 5; KYNURENINE; QUINOLINIC ACID; TRANSFORMING GROWTH FACTOR BETA1; TRYPTOPHAN;

ARTICLE; CYTOKINE PRODUCTION; DENDRITIC CELL; DERMIS; ENDOTHELIUM CELL; EOSINOPHIL COUNT; EOSINOPHILIA MYALGIA SYNDROME; EOSINOPHILIC FASCIITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUTROPHIL; PATHOGENESIS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; SKIN DISEASE; STAINING; TRYPTOPHAN METABOLISM;

EOSINOPHILIA; FASCIITIS; HUMANS; IMMUNOHISTOCHEMISTRY; QUINOLINIC ACID; TRYPTOPHAN;

EID: 33745684770     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-006-0096-5     Document Type: Article

References (27)

1. Freundlich B, Werth VP, Rook AH, O'Connor CR, Schumacher HR, Leyden JJ, Stolley PD (1990) L-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosis. Ann Intern Med 112:758-762
2. Grigoris I, de Launey W, Jetvic AP (1992) Eosinophilic fasciitis associated with L-tryptophan ingestion. Med J Aust 157:329-330
3. Martin RW, Duffy J, Engel AG, Lie JT, Bowles CA, Moyer TP, Gleich GJ (1990) The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Ann Intern Med 113:124-134
4. Blauvelt A, Falanga V (1991) Idiopathic and L-tryptophan-associated eosinophilic fasciitis before and after L-tryptophan contamination. Arch Dermatol 127:1159-1166
5. Silver RM, McKinley K, Smith EA, Quearry B, Harati Y, Sternberg EM, Heyes MP (1992) Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome. Arthritis Rheum 35:1097-1105
6. Wirleitner B, Neurauter G, Schrocksnadel K, Frick B, Fuchs D (2003) Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatrie aspects. Curr Med Chem 10:1581-1591
7. Silver RM, Sutherland SE, Carreira P, Heyes MP (1992) Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome. J Rheumatol 19:69-73
8. Silver RM, Heyes MP, Maize JC, Quearry B, Vionnet-Fuasset M, Sternberg EM (1990) Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med 322:874-881
9. Moffet JR, Namboodiri MA (2003) Tryptophan and the immune response. Immunol Cell Biol 81:247-265
10. Mayeno AN, Lin F, Foote CS, Loegering DA, Ames MM, Hedberg CW, Gleich GJ (1990) Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome. Science 250:1707-1708
11. Weiss G, Schroecksnadel K, Mattle V, Winkler C, Konwalinka G, Fuchs D (2004) Possible role of cytokine-induced tryptophan degradation in anaemia of inflammation. Eur J Haematol 72:130-134
12. Fallarino F, Grohmann U, Vacca C, Orabona C, Spreca A, Fioretti MC, Pucetti P (2003) T cell apoptosis by kynurenines. Adv Exp Med Biol 527:183-190
13. Friberg M, Jennings R, Alsarraj M, Dessureault S, Cantor A, Extermann M, Mellor AL, Munn DH, Antonia SJ (2002) Indoleamine 2,3-dioxygenase contributes to tumour cell evasion of T cell-mediated rejection. Int J Cancer 101:151-155
14. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191-1193
15. Taylor MW, Feng GS (1991) Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5:2516-2522
16. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL (1999) Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189:1363-1372
17. Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A, Fioretti MC, Pucetti P (2002) T cell apoptosis by tryptophan catabolism. Cell Death Differ 9:1069-1077
18. Yamazaki F, Kuroiwa T, Takikawa O, Kido R (1985) Human indolylamine 2,3-dioxygenase. Its tissue distribution, characterization of the placental enzyme. Biochem J 230:635-638
19. Naschitz JE, Yeshurun D, Zuckerman E, Rosenbaum M, Misselevitch I, Shajrawi I, Boss JH (1994) Cancer associated fasciitis panniculitis. Cancer 73:231-235
20. Hayashi N, Igarashi A, Matsuyama T, Harada S (2000) Eosinophilic fasciitis following exposure to trichloroethylene: successful treatment with cyclosporine. Br J Dermatol 142:830-832
21. + T-cell activation and induction of autoimmune hepatitis following tricholoroethylene treatment in MRL+/+ mice. Toxicol Sci 57:345-352
22. Satsangi J, Donaghy M (1992) Multifocal peripheral neuropathy in eosinophilic fasciitis. J Neurol 239:91-92
23. Heiman-Patterson TD, Bird SJ, Parry GJ, Varga J, Shy ME, Culligan NW et al (1990) Peripheral neuropathy associated with eosinophilia-myalgia syndrome. Ann Neurol 28:522-528
24. Heyes MP, Saito K, Markey SP (1992) Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochem J 283:633-635
25. Ito Y, Saito K, Maruta K, Nakagami Y, Koike T, Oguri Y, Nagamura Y (1999) Kynurenine concentration of serum was increased by exercise. Adv Exp Med Biol 467:717-722
26. Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-beta. Annu Rev Immunol 16:137-161
27. Ohno M, Cooke JP, Dzau Victor J, Gibbons GH (1995) Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. J Clin Invest 95:1363-1369